Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Relationship of grey and white matter abnormalities with distance from the surface of the brain in multiple sclerosis.
The immunomodulatory effect of laquinimod in CNS autoimmunity is mediated by the aryl hydrocarbon receptor.
Fingolimod enhances myelin repair of hippocampus in pentylenetetrazol-induced kindling model.
Krabbe disease: One Hundred years from the bedside to the bench to the bedside.
Guillain-Barré syndrome: What have we learnt during one century? A personal historical perspective.
Long-term real life efficacy of onabotulinum toxin A for the treatment of neurogenic detrusor overactivity in a population using intermittent self-catheterization.
PARP inhibition in leukocytes diminishes inflammation via effects on integrins/cytoskeleton and protects the blood-brain barrier.
Effects of small-fiber neuropathy induced by resiniferatoxin on skin healing and axonal regrowth after burn.
Altered T cell phenotypes associated with clinical relapse of multiple sclerosis patients receiving fingolimod therapy.
Smoking as a risk factor for developing Multiple Sclerosis: A meta-analysis of observational studies.
Cognitive performance, fatigue and event-related potentials in patients with clinically isolated syndrome.
Global gene expression profiles in brain regions reflecting abnormal neuronal and glial functions targeting myelin sheaths after 28-day exposure to cuprizone in rats.
Assessment of severity of neurogenic bowel dysfunction in chronic patients with a simple 1-item questionnaire (PGI-S).
Self-induced drug intoxication in baclofen: of the calm hypotonic coma in the status epilepticus.
Progressive Multiple Sclerosis.
High Intensity Training May Reverse the Fiber Type Specific Decline in Myogenic Stem Cells in Multiple Sclerosis Patients.
Reactive Oxygen Species Derived from NOX3 and NOX5 Drive Differentiation of Human Oligodendrocytes.
Predictors of the 10-year direct costs for treating multiple sclerosis.
Stent-assisted coil embolization of challenging intracranial aneurysms: initial and mid-term results with low-profile ACCLINO devices.
Cerebral blood flow modulation insufficiency in brain networks in multiple sclerosis: A hypercapnia MRI study.
Time- and Region-Specific Season of Birth Effects in Multiple Sclerosis in the United Kingdom.
Malignant chondroid syringoma in a West African cancer institute: A case report.
Social isolation impairs remyelination in mice through modulation of IL-6.
A Personalized Approach in Progressive Multiple Sclerosis: The Current Status of Disease Modifying Therapies (DMTs) and Future Perspectives.
Dysregulation of Chemokine/Chemokine Receptor Axes and NK Cell Tissue Localization during Diseases.
Pages
« first
‹ previous
…
835
836
837
838
839
840
841
842
843
…
next ›
last »